Dopamine transporter cocaine

Gelernter J, Kranzler HR, Satel SL, et al Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11 195-200, 1994... 

Malison RT, Best SE, van Dyck CH, et al Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [1231] beta-CIT SPECT. Am J... 

Figure 1.1 The dopamine transporter terminates the action of released dopamine by transport back into the presynaptic neuron. Dopamine transport occurs with the binding of one molecule of dopamine, one chloride ion, and two sodium ions to the transporter the transporter then translocates from the outside of the neuronal membrane into the inside of the neuron.22 Cocaine appears to bind to the sodium ion binding site. This changes the conformation of the chloride ion binding site thus dopamine transport does not occur. This blockade of dopamine transport potentiates dopaminergic neurotransmission and may be the basis for the rewarding effects of cocaine.

Kitayama, S., Shimada, S., Xu, H., Markham, L., Donovan, D.M., and Uhl, G.R., Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding, Proc. Natl. Acad. Sci. U.S.A., 89, 7782, 1992. 

Ritz, M.C., Lamb, R.J., Goldberg, S.R., and Kuhar, M.J., Cocaine receptors on dopamine transporters are related to self-administration of cocaine, Science, 237, 1219, 1987. 

Staley, J.K., Boja, J.W., Carroll, F.I., Seltzman, H.H., Wyrick, C.D., Lewin, A.H., Abraham, P., and Mash, D.C., Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121, Synapse, 21, 364, 1995. 

Calligaro, D.O. and Eldefraei, M.E., High affinity stereospecific binding of pH]cocaine in striatum and its relationship to the dopamine transporter, Membr. Biochem., 1, 87, 1988. 

Boja, J.W., Markham, L., Patel, A., Uhl, G., and Kuhar, M.J., Expression of a single dopamine transporter cDNA can confer two cocaine binding sites, Neuroreport, 3, 247, 1992. 

Carboni, E., Spielewoy, C., Vacca, C., Norten-Bertrand, M., Giros, B., and DiChiara, G., Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene, J. Neurosci., 21, 1, 2001. 

Mead, A.N., Rocha, B.A., Donovan, D.M., and Katz, J.L., Intravenous cocaine induced-activity and behavioral sensitization in norepinephrine-, but not dopamine-transporter knockout mice, Eur. J. Neurosci., 16, 514, 2002. 

Pill, C., Drobny, H., Reither, H., Homykiewicz, O., and Singer, E.A., Mechanism of the dopaminereleasing actions of amphetamine and cocaine plasmalemmal dopamine transporter versus vesicular monoamine transporter, Mol. Pharmacol., 47, 368, 1995. 

Giros, B., Jabar, M., Jones, S.R., Wightman, R.M., Caron, M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379 606, 1996. 

DA TRANSPORTER AND COCAINE DEPENDENCE 5.2.1 Regulation of the Dopamine Transporter (DAT) by Cocaine... 

Rocha B.A., Fumagalli F., Gainetdinov R.R. et al. Cocaine self-administration in dopamine-transporter knockout mice. Nat. Neurosci. 1 132, 1998. 

Hitri A., Little K., Ellinwood D. Effect of cocaine on dopamine transporter receptors depends on routes of chronic cocaine administration. Neuropsychopharmacology. 14 205, 1996. 

Letchworth S.R., Nader M.A., Smith H.R., Friedman D.P., Porrino LJ. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J. Neurosci. 21 2799, 2001. 

Little K., McLaughlin D., Zhang L. et al. Brain dopamine transporter messenger RNA and binding sites in cocaine users. Arch. Gen. Psychiatry. 55 793, 1998. 

Staley J., Basile M., Wetli C. et al. Differential regulation of the dopamine transporter in cocaine overdose deaths. Natl. Inst. Drug Abuse Res. Monogr. 32, 1994. 

Staley J., Hearn W., Ruttenber A., Weth C., Mash D. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. Pharmacol. Exp. Ther. 271 1678, 1994. 

Wilson J., Levey A., Bergeron C. et al. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann. Neurol. 40 428, 1996. 

Kunko P.M., Loeloff R.J., Izenwasser S. Chronic administration of the selective dopamine uptake inhibitor GBR 12,909, but not cocaine, produces marked decreases in dopamine transporter density. Naunyn Schmiedeberg s Arch. Pharmacol. 356 562, 1997. 

Mash D., Pablo J., Ouyang Q., Hearn W., Izenwasser S. Dopamine transport function is elevated in cocaine users. J. Neumchem. 81 292, 2002. 

Daws L., Callaghan P., Morom J. et al. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem. Biophys. Res. Commun. 290 1545, 2002. 

Little K., Elmer L., Zhong H., Scheys J., Zhang L. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol. Pharmacol. 61 436, 2002. 

Volkow N., Wang G., Fowler J. et al. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci. 65 7, 1999. 

Villemagne V., Rothman R., Yokoi F. et al. Doses of GBR 12909 that suppress cocaine self-administration in nonhuman primates substantially occupy dopamine transporters as measured by [UC]WIN 35,428 PET scans. Synapse. 32 44, 1999. 

Howell L., Wilcox K. The dopamine transporter and cocaine medication development drug selfadministration in nonhuman primates. J. Pharmacol. Exp. Ther. 298 1, 2001. 

Dworkin S.I., Lambert P., Sizemore G.M., Carroll F.I., Kuhar M.J. RTI-113 administration reduces cocaine self-administration at high occupancy of dopamine transporter. Synapse. 30 49, 1998. 

---